ALLR
Price
$1.02
Change
-$0.00 (-0.00%)
Updated
Jul 25 closing price
Capitalization
15.38M
RNAC
Price
$13.33
Change
-$0.13 (-0.97%)
Updated
Jul 25 closing price
Capitalization
345.97M
Interact to see
Advertisement

ALLR vs RNAC

Header iconALLR vs RNAC Comparison
Open Charts ALLR vs RNACBanner chart's image
Allarity Therapeutics
Price$1.02
Change-$0.00 (-0.00%)
Volume$310.87K
Capitalization15.38M
Cartesian Therapeutics
Price$13.33
Change-$0.13 (-0.97%)
Volume$38.76K
Capitalization345.97M
ALLR vs RNAC Comparison Chart in %
Loading...
ALLR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RNAC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALLR vs. RNAC commentary
Jul 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALLR is a StrongBuy and RNAC is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 26, 2025
Stock price -- (ALLR: $1.02 vs. RNAC: $13.33)
Brand notoriety: ALLR and RNAC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALLR: 64% vs. RNAC: 56%
Market capitalization -- ALLR: $15.38M vs. RNAC: $345.97M
ALLR [@Biotechnology] is valued at $15.38M. RNAC’s [@Biotechnology] market capitalization is $345.97M. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALLR’s FA Score shows that 1 FA rating(s) are green whileRNAC’s FA Score has 1 green FA rating(s).

  • ALLR’s FA Score: 1 green, 4 red.
  • RNAC’s FA Score: 1 green, 4 red.
According to our system of comparison, RNAC is a better buy in the long-term than ALLR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALLR’s TA Score shows that 6 TA indicator(s) are bullish while RNAC’s TA Score has 7 bullish TA indicator(s).

  • ALLR’s TA Score: 6 bullish, 3 bearish.
  • RNAC’s TA Score: 7 bullish, 3 bearish.
According to our system of comparison, RNAC is a better buy in the short-term than ALLR.

Price Growth

ALLR (@Biotechnology) experienced а +2.35% price change this week, while RNAC (@Biotechnology) price change was +12.58% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.58%. For the same industry, the average monthly price growth was +17.35%, and the average quarterly price growth was +27.29%.

Reported Earning Dates

ALLR is expected to report earnings on May 09, 2025.

RNAC is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (+7.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RNAC($346M) has a higher market cap than ALLR($15.4M). RNAC has higher P/E ratio than ALLR: RNAC (2.50) vs ALLR (0.00). ALLR YTD gains are higher at: -12.821 vs. RNAC (-25.572). ALLR has higher annual earnings (EBITDA): -23.16M vs. RNAC (-83.55M). RNAC has more cash in the bank: 180M vs. ALLR (25.2M). ALLR has less debt than RNAC: ALLR (1.36M) vs RNAC (14.1M). RNAC has higher revenues than ALLR: RNAC (34.2M) vs ALLR (0).
ALLRRNACALLR / RNAC
Capitalization15.4M346M4%
EBITDA-23.16M-83.55M28%
Gain YTD-12.821-25.57250%
P/E Ratio0.002.500%
Revenue034.2M-
Total Cash25.2M180M14%
Total Debt1.36M14.1M10%
FUNDAMENTALS RATINGS
RNAC: Fundamental Ratings
RNAC
OUTLOOK RATING
1..100
10
VALUATION
overvalued / fair valued / undervalued
1..100
99
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
49
P/E GROWTH RATING
1..100
21
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ALLRRNAC
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
88%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
66%
Bullish Trend 1 day ago
85%
Momentum
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
83%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
81%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
81%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
78%
Advances
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 3 days ago
82%
Declines
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 9 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 1 day ago
73%
View a ticker or compare two or three
Interact to see
Advertisement
ALLR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RNAC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CISO1.090.03
+2.83%
CISO Global
GLSI11.570.08
+0.70%
Greenwich LifeSciences
HASI27.920.09
+0.32%
HA Sustainable Infrastructure Capital Inc.
NPK105.020.26
+0.25%
National Presto Industries
DG107.56-0.19
-0.18%
Dollar General Corp

ALLR and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALLR has been closely correlated with TAOX. These tickers have moved in lockstep 87% of the time. This A.I.-generated data suggests there is a high statistical probability that if ALLR jumps, then TAOX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALLR
1D Price
Change %
ALLR100%
N/A
TAOX - ALLR
87%
Closely correlated
-5.51%
AGEN - ALLR
87%
Closely correlated
-1.32%
RNAC - ALLR
86%
Closely correlated
-0.97%
NCNA - ALLR
86%
Closely correlated
+10.37%
NRXP - ALLR
81%
Closely correlated
+0.33%
More